company background image
002370 logo

Zhejiang Yatai Pharmaceutical XSEC:002370 Stock Report

Last Price

CN¥3.40

Market Cap

CN¥2.5b

7D

7.3%

1Y

3.0%

Updated

17 May, 2025

Data

Company Financials

Zhejiang Yatai Pharmaceutical Co., Ltd.

XSEC:002370 Stock Report

Market Cap: CN¥2.5b

002370 Stock Overview

Researches, produces, sells, and exports pharmaceutical products in China and internationally. More details

002370 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Zhejiang Yatai Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Zhejiang Yatai Pharmaceutical
Historical stock prices
Current Share PriceCN¥3.40
52 Week HighCN¥4.38
52 Week LowCN¥2.21
Beta0.20
1 Month Change7.59%
3 Month Change-2.58%
1 Year Change3.03%
3 Year Change-31.45%
5 Year Change-28.87%
Change since IPO-79.24%

Recent News & Updates

Recent updates

Shareholder Returns

002370CN PharmaceuticalsCN Market
7D7.3%1.6%0.7%
1Y3.0%0.8%7.4%

Return vs Industry: 002370 exceeded the CN Pharmaceuticals industry which returned 0.8% over the past year.

Return vs Market: 002370 underperformed the CN Market which returned 7.4% over the past year.

Price Volatility

Is 002370's price volatile compared to industry and market?
002370 volatility
002370 Average Weekly Movement6.5%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement7.0%
10% most volatile stocks in CN Market10.4%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 002370 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002370's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1989529Jianwei Cenwww.ytyaoye.com

Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. Zhejiang Yatai Pharmaceutical Co., Ltd.

Zhejiang Yatai Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Yatai Pharmaceutical's earnings and revenue compare to its market cap?
002370 fundamental statistics
Market capCN¥2.54b
Earnings (TTM)CN¥29.43m
Revenue (TTM)CN¥357.01m

86.1x

P/E Ratio

7.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002370 income statement (TTM)
RevenueCN¥357.01m
Cost of RevenueCN¥252.86m
Gross ProfitCN¥104.16m
Other ExpensesCN¥74.72m
EarningsCN¥29.43m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.039
Gross Margin29.17%
Net Profit Margin8.24%
Debt/Equity Ratio3.0%

How did 002370 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/17 01:05
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zhejiang Yatai Pharmaceutical Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jie YaoEverbright Securities Co. Ltd.
Fenghua WangShenwan Hongyuan Securities